Cargando…
Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292434/ http://dx.doi.org/10.1186/2051-1426-2-S3-P213 |
_version_ | 1782352484318052352 |
---|---|
author | Horton, Brendan Spranger, Stefani Williams, Jason Gajewski, Thomas |
author_facet | Horton, Brendan Spranger, Stefani Williams, Jason Gajewski, Thomas |
author_sort | Horton, Brendan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4292434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42924342015-01-15 Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors Horton, Brendan Spranger, Stefani Williams, Jason Gajewski, Thomas J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292434/ http://dx.doi.org/10.1186/2051-1426-2-S3-P213 Text en Copyright © 2014 Horton et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Horton, Brendan Spranger, Stefani Williams, Jason Gajewski, Thomas Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors |
title | Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors |
title_full | Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors |
title_fullStr | Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors |
title_full_unstemmed | Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors |
title_short | Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors |
title_sort | agonistic 4-1bb antibodies in combination with inhibitory antibodies against ctla-4, pd-l1 or lag-3 act on cd8+ t cells in the tumor microenvironment and synergize to promote regression of established tumors |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292434/ http://dx.doi.org/10.1186/2051-1426-2-S3-P213 |
work_keys_str_mv | AT hortonbrendan agonistic41bbantibodiesincombinationwithinhibitoryantibodiesagainstctla4pdl1orlag3actoncd8tcellsinthetumormicroenvironmentandsynergizetopromoteregressionofestablishedtumors AT sprangerstefani agonistic41bbantibodiesincombinationwithinhibitoryantibodiesagainstctla4pdl1orlag3actoncd8tcellsinthetumormicroenvironmentandsynergizetopromoteregressionofestablishedtumors AT williamsjason agonistic41bbantibodiesincombinationwithinhibitoryantibodiesagainstctla4pdl1orlag3actoncd8tcellsinthetumormicroenvironmentandsynergizetopromoteregressionofestablishedtumors AT gajewskithomas agonistic41bbantibodiesincombinationwithinhibitoryantibodiesagainstctla4pdl1orlag3actoncd8tcellsinthetumormicroenvironmentandsynergizetopromoteregressionofestablishedtumors |